Lilly

Sandy Huffaker for The Washington Post via Getty ImagesEli Lilly stock could soar 140% by 2028 as millions of Americans begin to take their GLP-1 weight loss drugs, according to Goldman Sachs.The firm estimated that if all GLP-1 trials…

Fokusiert Heading into the biopharma Q3 earnings season, Bank of America has taken a bullish stance on Eli Lilly (NYSE:LLY) and Gilead (NASDAQ:GILD) while raising concerns on COVID-era favorites such as Pfizer (NYSE:PFE) and Regeneron…

Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 agonists to bring over $100B in annual sales by 2030 in a duopoly controlled by Novo Nordisk…

Dmitry Dzhimidovich As investors prepare for another challenging quarter when earnings season begins in the biopharmaceutical business later this month, Barclays has picked Eli Lilly (New York Stock Exchange: LLY) and Merck (New York…

© Reuters. FILE PHOTO: The Eli Lilly logo is seen on one of the company's offices in San Diego, California, US, September 17, 2020. REUTERS/Mike Blake/File Photo By Sribarna Roy (Reuters) - Eli Lilly and Associates said on Friday it…

iQoncept Buoyed by booming diabetes drug sales, Eli Lilly (New York Stock Exchange: LLY) was the best performer in big pharma or biotech in the first half of 2023, returning dazzling 28%. Coming in at number two, Vertex Pharmaceuticals…

Eli Lilly will spend nearly $2.4 billion to acquire Dice Therapeutics to create more drugs to combat autoimmune diseases. American pharmaceutical company Eli Lilly has announced that it intends to buy biopharmaceutical company Dice…

room mom Scribe Therapeutics is partnering with the Eli Lilly unit (New York Stock Exchange: LLYTherapeutics prevail and grant rights to CRISPR X-Editing (XE) technologies to develop in vivo treatments for neuromuscular diseases. Under…

2/2 © Reuters. FILE PHOTO: Dr. Seth Gill points to evidence of Alzheimer's disease in positron emission tomography scans at the Center for Alzheimer's Disease Research and Treatment (CART) at Brigham and Women's Hospital in Boston,…